HIGHLIGHTS
- who: Photodynamic Therapy and colleagues from the Center for Optical Diagnostics and, Department of Radiation Oncology, Erasmus, The Netherlands, Department of Internal Medicine, Erasmus School of Medicine, Washington University, StLouis, Missouri, United States of America, Department of Immunology, Erasmus Medical Center, The have published the article: Somatostatin Analogues for Receptor Targeted Photodynamic Therapy, in the Journal: PLOS ONE | www.plosone.org of August/11,/2014
- what: The authors report on a novel dual approach of targeted PDT (vascular and cellular targeting) utilizing the expression of neuropeptide somatostatin receptor (sst2) on tumor and neovascular-endothelial cells . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.